ValiRx (LON:VAL) Stock Crosses Below 200 Day Moving Average – Here’s Why

ValiRx plc (LON:VAL)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 2 ($0.03) and traded as low as GBX 0.71 ($0.01). ValiRx shares last traded at GBX 0.72 ($0.01), with a volume of 9,620,656 shares.

ValiRx Trading Down 1.7 %

The company has a market capitalization of £943,655.50, a PE ratio of -35.65 and a beta of 0.59. The company has a quick ratio of 1.27, a current ratio of 6.65 and a debt-to-equity ratio of 0.49. The stock’s 50 day moving average is GBX 1.39 and its two-hundred day moving average is GBX 1.98.

ValiRx Company Profile

ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a short peptide that has completed Phase I/II trials for the treatment of prostate cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of end-stage non-small cell lung cancer.